Report Detail

Request for Sample of this report

Other Global 23-Valent Pneumococcal Polysaccharide Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2940077
    • |
  • 14 February, 2019
    • |
  • Global
    • |
  • 108 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.

23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.

Scope of the Report:
North America is the largest supplier and consumption market of 23-Valent Pneumococcal Polysaccharide Vaccine, with a production market share nearly 70% and sales market share nearly 28% in 2015. Because Sanofipasteur, a competitor from Europe, transferred its vaccine type gradually, the production market share of North America in the world has enjoyed a dramatic increase.
The second place is EU, following North America with production market share of 15% and sales market share nearly 20% in 2015.China is another important market of 23-Valent Pneumococcal Polysaccharide Vaccine, enjoying 10% production market share and 15% sales market share in 2015.
The worldwide market for 23-Valent Pneumococcal Polysaccharide Vaccine is expected to grow at a CAGR of roughly 16.3% over the next five years, will reach 3830 million US$ in 2024, from 1550 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the 23-Valent Pneumococcal Polysaccharide Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
MSD
Sanofipasteur
CDIBP

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Single Dose Vial
Pre-filled Syringe

Market Segment by Applications, can be divided into
For Children (2-10)
For Person (10-64)
For The Old (≥65)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 23-Valent Pneumococcal Polysaccharide Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, with price, sales, revenue and global market share of 23-Valent Pneumococcal Polysaccharide Vaccine in 2017 and 2018.
Chapter 3, the 23-Valent Pneumococcal Polysaccharide Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 23-Valent Pneumococcal Polysaccharide Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, 23-Valent Pneumococcal Polysaccharide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe 23-Valent Pneumococcal Polysaccharide Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 23-Valent Pneumococcal Polysaccharide Vaccine Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Single Dose Vial
      • 1.2.2 Pre-filled Syringe
    • 1.3 Market Analysis by Applications
      • 1.3.1 For Children (2-10)
      • 1.3.2 For Person (10-64)
      • 1.3.3 For The Old (≥65)
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 MSD
      • 2.1.1 Business Overview
      • 2.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Sanofipasteur
      • 2.2.1 Business Overview
      • 2.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 CDIBP
      • 2.3.1 Business Overview
      • 2.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2018
      • 3.3.2 Top 6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis by Regions

    • 4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Regions
      • 4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 4.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 4.5 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)

    5 North America 23-Valent Pneumococcal Polysaccharide Vaccine by Country

    • 5.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
      • 5.1.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2014-2019)
    • 5.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 5.3 Canada 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 5.4 Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)

    6 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country

    • 6.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
      • 6.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 6.3 UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 6.4 France 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 6.5 Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 6.6 Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)

    7 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine by Country

    • 7.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2014-2019)
    • 7.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 7.3 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 7.4 Korea 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 7.5 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)

    8 South America 23-Valent Pneumococcal Polysaccharide Vaccine by Country

    • 8.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
      • 8.1.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 8.3 Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 8.4 Colombia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)

    9 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Countries

    • 9.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 9.3 Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 9.4 Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)
    • 9.6 South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2014-2019)

    10 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment by Type

    • 10.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2014-2019)
    • 10.2 Single Dose Vial Sales Growth and Price
      • 10.2.1 Global Single Dose Vial Sales Growth (2014-2019)
      • 10.2.2 Global Single Dose Vial Price (2014-2019)
    • 10.3 Pre-filled Syringe Sales Growth and Price
      • 10.3.1 Global Pre-filled Syringe Sales Growth (2014-2019)
      • 10.3.2 Global Pre-filled Syringe Price (2014-2019)

    11 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment by Application

    • 11.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2014-2019)
    • 11.2 For Children (2-10) Sales Growth (2014-2019)
    • 11.3 For Person (10-64) Sales Growth (2014-2019)
    • 11.4 For The Old (≥65) Sales Growth (2014-2019)

    12 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)

    • 12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Regions (2019-2024)
      • 12.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
      • 12.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
      • 12.2.4 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2019-2024)
    • 12.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Type (2019-2024)
      • 12.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2019-2024)
      • 12.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Type (2019-2024)
    • 12.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast by Application (2019-2024)
      • 12.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2019-2024)
      • 12.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on 23-Valent Pneumococcal Polysaccharide Vaccine . Industry analysis & Market Report on 23-Valent Pneumococcal Polysaccharide Vaccine is a syndicated market report, published as Global 23-Valent Pneumococcal Polysaccharide Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,686.56
      		4,029.84
      		5,373.12
      		3,198.12
      		4,797.18
      		6,396.24
      		529,203.60
      		793,805.40
      		1,058,407.20
      		292,876.80
      		439,315.20
      		585,753.60
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo